Axelar AB (Axelar)

Oncology Corporate Profile

HQ Location

Karolinska Institutet Science Park, Fogdevreten 2A
Solna, Sweden SE-171 65

Company Description

Axelar AB is a Swedish biotech company founded in 2003. The company is developing insulin-like growth factor-1 (IGF-1) receptor inhibitors for treatment of cancer and other diseases. Axelar is part of the Karolinska Development portfolio of companies.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
AXL1717insulin-like growth factor-1 (IGF-1) receptor inhibitorNon Small Cell Lung Cancer (NSCLC)II
AXL1717insulin-like growth factor-1 (IGF-1) receptor inhibitorVarious cancer typesI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display